MD1003 ‘effective’ in Phase III trial
MD1003 ‘effective’ in Phase III trial
Data from an extension phase of a Phase III clinical trial claims the biotin MD1003 showed effectiveness over time as a possible treatment of non-active, progressive multiple sclerosis (MS)...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/